Novartis (NVS) News Today $110.31 -0.78 (-0.70%) Closing price 03/25/2025 03:58 PM EasternExtended Trading$110.83 +0.52 (+0.47%) As of 03/25/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Mill Capital Management LLC Cuts Stock Position in Novartis AG (NYSE:NVS)Mill Capital Management LLC decreased its position in shares of Novartis AG (NYSE:NVS - Free Report) by 33.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,851 shares of the compaMarch 25 at 5:54 AM | marketbeat.comNovartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosisMarch 25 at 2:15 AM | globenewswire.comSei Investments Co. Buys 16,519 Shares of Novartis AG (NYSE:NVS)Sei Investments Co. increased its position in Novartis AG (NYSE:NVS - Free Report) by 3.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 531,885 shares of the company's stock after purcMarch 24 at 5:10 AM | marketbeat.comVirtu Financial LLC Has $1 Million Stake in Novartis AG (NYSE:NVS)Virtu Financial LLC boosted its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 176.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,275 shares of the company's stock after buying an additional 6,56March 24 at 4:59 AM | marketbeat.comMarietta Investment Partners LLC Has $1.73 Million Stock Position in Novartis AG (NYSE:NVS)Marietta Investment Partners LLC lowered its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 15.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,814 shares of the company'March 23 at 7:02 AM | marketbeat.com36,154 Shares in Novartis AG (NYSE:NVS) Bought by Summit Global InvestmentsSummit Global Investments bought a new position in Novartis AG (NYSE:NVS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 36,154 shares of the company's stock, valued at approximately $3,518,000. A numbMarch 23 at 5:50 AM | marketbeat.comMillstone Evans Group LLC Acquires Shares of 3,132 Novartis AG (NYSE:NVS)Millstone Evans Group LLC acquired a new stake in Novartis AG (NYSE:NVS - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 3,132 shares of the company's stock, valued at approximately $305,000. Several otheMarch 23 at 5:49 AM | marketbeat.comNovartis AG (NYSE:NVS) Shares Purchased by Boston PartnersBoston Partners raised its stake in Novartis AG (NYSE:NVS - Free Report) by 44.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,359 shares of the company's stock after acquiring an additionalMarch 23 at 4:39 AM | marketbeat.comAxxcess Wealth Management LLC Purchases 4,267 Shares of Novartis AG (NYSE:NVS)Axxcess Wealth Management LLC boosted its position in shares of Novartis AG (NYSE:NVS - Free Report) by 151.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,083 shares of the company's stock after purchasing an additional 4,2March 23 at 4:18 AM | marketbeat.comWhittier Trust Co. Has $5.13 Million Holdings in Novartis AG (NYSE:NVS)Whittier Trust Co. lifted its position in shares of Novartis AG (NYSE:NVS - Free Report) by 10.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 52,678 shares of the company's stock after buying an additiMarch 22, 2025 | marketbeat.comBerkeley Capital Partners LLC Cuts Stock Holdings in Novartis AG (NYSE:NVS)Berkeley Capital Partners LLC reduced its stake in Novartis AG (NYSE:NVS - Free Report) by 60.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,408 shares of the company's stock after selling 3,608 shares during the quarter.March 22, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Cuts Stake in Novartis AG (NYSE:NVS)Connor Clark & Lunn Investment Management Ltd. lowered its position in Novartis AG (NYSE:NVS - Free Report) by 95.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,433 shares of tMarch 22, 2025 | marketbeat.comNovartis gets third FDA approval for oral FabhaltaMarch 21, 2025 | markets.businessinsider.comNovartis’s treatment of leishmaniasis granted FDA orphan designationMarch 21, 2025 | markets.businessinsider.comWilkins Investment Counsel Inc. Has $16.23 Million Stake in Novartis AG (NYSE:NVS)Wilkins Investment Counsel Inc. trimmed its position in shares of Novartis AG (NYSE:NVS - Free Report) by 11.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 166,782 shares of the company's stock aMarch 21, 2025 | marketbeat.comStokes Family Office LLC Invests $436,000 in Novartis AG (NYSE:NVS)Stokes Family Office LLC bought a new position in Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,484 shares of the company's stock, valued at approxiMarch 21, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Boosts Stock Holdings in Novartis AG (NYSE:NVS)Charles Schwab Investment Management Inc. boosted its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 5.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 165,442 shares of the company's stockMarch 21, 2025 | marketbeat.comMarch 20, 2025 | gurufocus.comNovartis receives third FDA approval for oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)March 20, 2025 | prnewswire.comNovartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)March 20, 2025 | globenewswire.comSwiss drugmakers Novartis and Roche ditch some diversity programmes on US concernsMarch 20, 2025 | msn.comNovartis AG (NYSE:NVS) Shares Bought by First Financial Bankshares IncFirst Financial Bankshares Inc boosted its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 214,585 shares of the company's stock after buMarch 20, 2025 | marketbeat.comForesight Global Investors Inc. Buys 7,550 Shares of Novartis AG (NYSE:NVS)Foresight Global Investors Inc. raised its stake in Novartis AG (NYSE:NVS - Free Report) by 3.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 232,366 shares of the company's stock after buying an additional 7,550 shares during the quarter. NovartisMarch 20, 2025 | marketbeat.comProVise Management Group LLC Has $12.59 Million Stake in Novartis AG (NYSE:NVS)ProVise Management Group LLC trimmed its holdings in Novartis AG (NYSE:NVS - Free Report) by 1.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 129,359 shares of the company's stock aMarch 20, 2025 | marketbeat.comEnvestnet Portfolio Solutions Inc. Has $3.61 Million Stake in Novartis AG (NYSE:NVS)Envestnet Portfolio Solutions Inc. lifted its stake in Novartis AG (NYSE:NVS - Free Report) by 12.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 37,063 shares of the company's stocMarch 20, 2025 | marketbeat.comNovartis (NYSE:NVS) versus Sonnet BioTherapeutics (NASDAQ:SONN) Critical ComparisonMarch 20, 2025 | americanbankingnews.comNovartis announces results from Phase III program for OAV101 ITMarch 20, 2025 | markets.businessinsider.comNovartis scraps use of diverse panels for hires in USMarch 19, 2025 | reuters.comRD Lewis Holdings Inc. Takes $816,000 Position in Novartis AG (NYSE:NVS)RD Lewis Holdings Inc. bought a new position in Novartis AG (NYSE:NVS - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 7,676 shares of the company's stock, valued at approximately $816,000. A number of other institutional investors also recentlMarch 19, 2025 | marketbeat.comShort Interest in Novartis AG (NYSE:NVS) Increases By 26.3%Novartis AG (NYSE:NVS - Get Free Report) saw a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 5,040,000 shares, an increase of 26.3% from the February 13th total of 3,990,000 shares. Based on an average daily volume of 1,770,000 shares, the short-interest ratio is currently 2.8 days. Approximately 0.3% of the company's stock are sold short.March 18, 2025 | marketbeat.comNovartis (NYSE:NVS) Sees Strong Trading Volume - Here's WhyNovartis (NYSE:NVS) Sees Strong Trading Volume - Still a Buy?March 18, 2025 | marketbeat.comEdgemoor Investment Advisors Inc. Cuts Holdings in Novartis AG (NYSE:NVS)Edgemoor Investment Advisors Inc. decreased its holdings in Novartis AG (NYSE:NVS - Free Report) by 5.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 119,683 shares of the company's stock after selling 6,761 shares during the period.March 18, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA lowered its position in Novartis AG (NYSE:NVS - Free Report) by 8.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,025,039 shares of the company's stock after sellingMarch 18, 2025 | marketbeat.comTocqueville Asset Management L.P. Grows Stock Holdings in Novartis AG (NYSE:NVS)Tocqueville Asset Management L.P. increased its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 10.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 118,913 shares of the comMarch 18, 2025 | marketbeat.comCorient Private Wealth LLC Reduces Stock Holdings in Novartis AG (NYSE:NVS)Corient Private Wealth LLC decreased its position in shares of Novartis AG (NYSE:NVS - Free Report) by 6.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 541,528 shares of the company's stock after selling 38,26March 18, 2025 | marketbeat.comBerenberg Bank Remains a Hold on Novartis (NVS)March 18, 2025 | markets.businessinsider.comNovartis is watching US reciprocal tariff policy 'very carefully', CEO saysMarch 17, 2025 | msn.comPatten & Patten Inc. TN Sells 2,625 Shares of Novartis AG (NYSE:NVS)Patten & Patten Inc. TN trimmed its position in shares of Novartis AG (NYSE:NVS - Free Report) by 8.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 30,060 shares of the company's stock after selling 2,625 shares during tMarch 17, 2025 | marketbeat.comChoate Investment Advisors Buys 3,910 Shares of Novartis AG (NYSE:NVS)Choate Investment Advisors raised its stake in Novartis AG (NYSE:NVS - Free Report) by 11.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 36,683 shares of the company's stock after purchasinMarch 17, 2025 | marketbeat.comNatixis Advisors LLC Trims Holdings in Novartis AG (NYSE:NVS)Natixis Advisors LLC decreased its position in shares of Novartis AG (NYSE:NVS - Free Report) by 7.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 872,465 shares of the company's stock after selling 66,379 shares during the period. Natixis Advisors LLCMarch 17, 2025 | marketbeat.comone8zero8 LLC Takes $279,000 Position in Novartis AG (NYSE:NVS)one8zero8 LLC bought a new position in shares of Novartis AG (NYSE:NVS - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,864 shares of the company's stock, valued at approximately $279,000. Other heMarch 17, 2025 | marketbeat.comCommonwealth Equity Services LLC Has $24.67 Million Position in Novartis AG (NYSE:NVS)Commonwealth Equity Services LLC raised its stake in Novartis AG (NYSE:NVS - Free Report) by 24.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 253,467 shares of the company's stock after acquiring aMarch 17, 2025 | marketbeat.comNovartis CEO says it is watching US reciprocal tariff policy 'very carefully'March 17, 2025 | reuters.comBrandes Investment Partners LP Sells 3,989 Shares of Novartis AG (NYSE:NVS)Brandes Investment Partners LP cut its position in Novartis AG (NYSE:NVS - Free Report) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 209,770 shares of the company's stock after selling 3,989 shares during the quarter. BrMarch 16, 2025 | marketbeat.comZevin Asset Management LLC Increases Position in Novartis AG (NYSE:NVS)Zevin Asset Management LLC raised its position in Novartis AG (NYSE:NVS - Free Report) by 14.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 100,637 shares of the company's stock after purchasing an aMarch 16, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Purchased by Diamond Hill Capital Management Inc.Diamond Hill Capital Management Inc. boosted its stake in Novartis AG (NYSE:NVS - Free Report) by 13.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 30,715 shares of the company's stock after purchasing an additional 3,715 shares during the period. Diamond HiMarch 16, 2025 | marketbeat.comAvantax Advisory Services Inc. Has $2.91 Million Stake in Novartis AG (NYSE:NVS)Avantax Advisory Services Inc. raised its position in shares of Novartis AG (NYSE:NVS - Free Report) by 10.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,938 shares of the company's stocMarch 16, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Stock Holdings Lowered by HighTower Advisors LLCHighTower Advisors LLC cut its position in Novartis AG (NYSE:NVS - Free Report) by 19.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 235,353 shares of the company's stock after selling 55,507 shares duringMarch 16, 2025 | marketbeat.comNovartis AG (NOVN) Gets a Buy from Kepler CapitalMarch 15, 2025 | theglobeandmail.comQuantbot Technologies LP Raises Stock Holdings in Novartis AG (NYSE:NVS)Quantbot Technologies LP boosted its position in Novartis AG (NYSE:NVS - Free Report) by 87.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 74,871 shares of the company's stock after buying an additioMarch 15, 2025 | marketbeat.com Remove Ads Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼0.980.77▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼3014▲NVS Articles Average Week Remove Ads Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News SNY News GSK News TAK News ARGX News ONC News BNTX News TEVA News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVS Stock Free NVS Stock Alerts